2.1. Pt(η3–P1O1P2)(P3)
Monoclinic [Pt{η
3-Ph
2P(C
15H
12O)PPh
2}{η
1–P
3(C
5H
4N)(Ph)
2}](CF
3SO
3)
2•0.5H
2O
[19] (at 150 K) is the only example of the P
1C
2O
1C
2P
2 metallocycle type. The heterotridentate η
3-P
1O
1P
2 ligand with monodentate P
3L creates a distorted square planar geometry around a Pt(II) atom.
The total mean Pt–L bond distance elongates in the following sequences:
Pt (η3-P1O1P2)(Y), Y = P3L (1 example): Pt–L: 2.189 (3) Å (O1, trans to P3) < 2.239 (2) Å (P3) < 2.302 (2,11) Å (P1,2, mutually trans)
2.2. Pt(η3–P1N1P2)(Y), (Y = N2 L, (x1), CL(x9), Cl(x7), P3L(x2))
There are nineteen examples of the P
1C
2N
1C
2P
2 metallocyclic type with a common N
1 atom. Monoclinic [Pt{η
3-Ph
2P(C
12H
8N)PPh
2}(N
2C
5H
5)]CF
3SO
3.toluene
[20] is the only example in which a N
2 donor ligand completed a square planar geometry around a Pt(II) atom (PtP
1N
1P
2N
2). The structure of [Pt{η
3-Ph
2P(C
12H
8N)PPh
2}(N
2C
5H
5)]
+ [20] is shown in
Figure 1 as an example.
Figure 1. Structure of [Pt{η3-Ph2P(C12H8N)PPh2}(py)].
In the following eight complexes, triclinic [Pt{η
3-Bu
t2P(C
7H
7N)PBu
t2}(CH
3)]Cl (at 100 K), monoclinic [Pt{η
3-Bu
t2P(C
7H
6N)PBu
t2}(CH
3)]
[21] (at 100 K), monoclinic [Pt{η
3-Ph
2P(C
7H
7N)PPh
2}{C(=O)Et}]BF
4.(CH
2Cl
2)
5 [22] (at 100 K), triclinic [Pt{η
3-Ph
2P(C
7H
7N)PPh
2}(CH
2CHO)]BF
4 [22], triclinic [Pt{η
3-Ph
2P(C
7H
7N)PPh
2}(CH=CHPh)]BF
4 [23], monoclinic [Pt{η
3-Pr
i2P(C
12H
7F
2N)PPr
i2}(C
6H
4F)]B(C
6H
5)
4 (at 110 K) and monoclinic [Pt{η
3-Pri
2P(C
12H
7F
2N)PPr
i2}. (p-toluene)]B(C
6H
5)
4 [24] (at 110 K), and monoclinic [Pt{η
3-Ph
2P(C
7H
7N)PPr
i2}(η
1-C
11H
15NO
3)]BF
4 [25] and a η
3-P
1N
1P
2 ligand with a monodentate CL create a distorted square planar geometry around a Pt(II) atom (PtP
1N
1P
2C).
There are seven complexes, monoclinic [Pt{η
3-Ph
2P(C
12H
8N)PPh
2}(Cl)](C
6H
6)
5 [20], trigonal [Pt{η
3-Bu
t2P(C
7H
7N)PBu
t2}(Cl)]Cl
[21], orthorhombic [Pt{η
3-Bu
t2P(C
7H
6N)PBu
t2}(Cl)]
[21] (at 120 K), monoclinic [Pt{η
3-Pr
i2P(C
12H
6F
2N)PPr
i2}(Cl)]CHB
11Cl
11 [24] (at 110 K), monoclinic [Pt{η
3-Ph
2P(C
14H
12N)PPr
i2}(Cl)]C
6H
6 [26] (at 183 K) and triclinic [Pt{η
3-Ph
2P(C
14H
12N)Pcy
2}(Cl)]C
6H
6 [26] (at 183 K), and monoclinic [Pt{η
3-Ph
2P(C
7H
8N)PPh
2}(Cl)]
[27] in which Cl
− anions complete inner coordinate spheres (PtP
1N
1P
2Cl).
In the remaining two complexes, triclinic [Pt{η
3-(η
2-(C
24H
44)P(C
7H
6N)P(C
24H
44)} (PPh
3)].2CH
2Cl
2 [28] (at 103 K) and monoclinic [Pt{η
3-(η
2-C
18H
28)P(C
7H
6N)P(η
2-C
18H
29)}(P
3cy
3)]
[29] (at 103 K), a monodentate P
3L is involved (PtP
1N
1P
2P
3).
The total mean Pt-L bond distance elongates in the following sequences:
Pt (η3-P1N1P2)(Y), Y = N2L, CL, Cl, P3L (19 examples): Pt–N1: (trans to Y): 2.024 (3) Å (N2) < 2.077 (2,5) Å (P3) < 2.128 (2,70) Å (C) < 2.201 (3,26) Å (Cl); Pt–Y: (trans to N1): 2.056 (3) Å (N2) < 2.072 (2,85) Å (C) < 2.277 (2,5) Å (P3) < 2.316 (2,17) Å (Cl); Pt–P1,2: (mutually trans) is 2.287 (2,17) Å
2.3. Pt(η3–P1C1P2)(Y), (Y = OL (x4), NL(x4), C2L (x9), Cl (x12), Br (x2))
There are over thirty examples of the P
1C
2C
1C
2P
2 metallocycle type. In four complexes, monoclinic [Pt{η
3-(CF
3)
2P(C
8H
7)P(CF
3)
2}(H
2O)].SbF
6 [30], triclinic [Pt{η
3-Ph
2P(C
8H
7)Ph
2P}(H
2O)]CF
3SO
3 [31], triclinic [Pt{η
3-Ph
2P(C
8H
7)PPh
2}(OMe)]0.5C
6H
6 [31], and orthorhombic [Pt{η
3-Pr
i2P(C
20H
11)PPr
i2}(OOCCF
3)]
[32] (
Figure 2), a monodentate OL ligand completed a square planar geometry (PtP
1C
1P
2O).
Figure 2. Structure of [Pt{η3-Pri2P(C20H11)PPri2}(OOCCF3)].
In four complexes, monoclinic [Pt{η
3-(CF
3)
2P(C
8H
7)P(CF
3)
2} (NC
5H
5)]B(C
6H
5)
4 [30], orthorhombic [Pt{η
3-Ph
2P(C
20H
13O
4)PPh
2}(N≡CCH
3)]BF
4 [32], monoclinic [Pt{η
3-Ph
2P(C
20H
11O
2)PPh
2}(NC
5H
5)]Cl}](NC
5H
5)
[33], and monoclinic [Pt{η
3-Ph
2P(C
20H
11O
4)PPh
2} (N≡CCH
3)]BF
4. CH
2Cl
2 [33], monodentate NL ligands completed the inner coordination sphere PtP
1N
1P
2N
2.
There are nine complexes, tetragonal [Pt{η
3-Ph
2P(C
24H
19O
2)PPh
2}(CN)]
[34], triclinic [Pt{η
3-(CF
3)
2P(C
8H
7)P(CF
3)
2}(CO)]SbF
6 [35], monoclinic [Pt{η
3-(CF
3)
2P(C
8H
7)P(CF
3)
2}(CH
3)]
[35], monoclinic [Pt{η
3-Pr
i2P(C
8H
7)PPr
i2}(CO)]CF
3SO
3 0.5C
6H
6 [36], monoclinic [Pt{η
3-Bu
t2P(C
8H
7)PBu
t2}(η
1-CHOMe)]CF
3SO
3.thf
[36], orthorhombic [Pt{η
3-Bu
t2P(C
12H
9)PBu
t2}(CO)]BF
4 [37], monoclinic [Pt{η
3-Ph
2P(C
8H
7)PPh
2}(η
1-C
12H
19N
2)]
[38], monoclinic [Pt{η
3-Ph
2P(C
6H
7N
2)PPh
2}(η
1-C
3F
2)]
[39], and monoclinic [Pt{η
3-Ph
2P(C
8H
7)PPh
2}(η
1-C
12H
21N
2)]2(BF
4)
[40], in which a monodentate C
2L ligands are involved (PtP
1C
1P
2C
2).
In twelve complexes, triclinic [Pt{η
3-Ph
2P(C
20H
11O
2)PPh
2}(Cl)](CH
3CN)
4 [33], monoclinic [Pt{η
3-Ph
2P(C
24H
19O
2)PPh
2}(Cl)]
[34], monoclinic [Pt{η
3-(CF
3)
2P(C
8H
7)P(CF
3)
2}(Cl)]1.5C
6H
14 [35], orthorhombic [Pt{η
3-Bu
t2P(C
8H
7)PBu
t2}(Cl)]
[36], monoclinic [Pt{η
3-Bu
t2P(C
12H
9)PBu
t2}(Cl)]
[37], monoclinic [Pt{η
3-Bu
t2P(C
8H
7)PBu
t2}(Cl)]
[41], triclinic [Pt{η
3-Pr
i2P(C
8H
7)PPr
i2}(Cl)]
[42], monoclinic [Pt{η
3-Ph
2P(C
14H
7)PPh
2}(Cl)]
[43], monoclinic [Pt{η
3-Ph
2P(C
8H
7)PPh
2}(Cl)]CH
3CN
[44], orthorhombic [Pt{η
3-Ph
2P(C
18H
11O
8)PPh
2}(Cl)]CH
3CN
[44], orthorhombic [Pt{η
3-Ph
2P(C
18H
11O
8)PPh
2}(Cl)]CH
2C
l2 [45], and monoclinic [Pt{η
3-Pr
i2P(C
20H
11)PPr
i2}(Cl)](CH
3CN)
2 [46], a Cl
− anion completed inner coordination spheres around each Pt(II) atom (PtP
1C
1P
2Cl).
A Br
− anion is involved in two monoclinic complexes, [Pt{η
3-Ph
2P(C
8H
7)PPh
2}(Br)]
[47] and [Pt{η
3-Bu
t2P(C
8H
7)PBu
t2}(Br)]
[48].
The total mean PL-L bond distance elongates in the following sequences:
Pt (η3-P1C1P2)(Y), Y = OL, NL, C2L Cl, Br (31 examples): Pt–C1: (trans to Y): 2.001 (3,8) Å (N) < 2.027 (2,8) Å (O) ~ 2.027 (2,6) Å (Br) < 2.031 (2,12) Å (Cl) < 2.049 (2) Å (C2); Pt–Y: (trans to C1): 2.065 (7,12) Å (C2) < 2.085 (2,12) Å (N) < 2.132 (2,9) Å (O) < 2.400 (2,16) Å (Cl) < 2.467 (1,10) Å (Br); Pt–P1,2: (mutually trans) is 2.75 (2,12) Å.
2.4. Pt(η3–P1S1P2)(Y), (Y = CH3 (x1), Cl (x2), P3Ph3 (x2), I (x1))
There are six complexes in which each heterotridentate ligand creates a P
1C
2S
1C
2P
2 metallocycle. Monoclinic [Pt{η
3-Ph
2P(C
6H
4)S(=O)(C
6H
4)PPh
2}(CH
3)]PF
6.CH
3CN
[49] (at 100 K;
Figure 3) is the only example with a (PtP
1S
1P
2C) chromophore. In monoclinic [Pt{η
3-Ph
2P(C
6H
4)S(=O)(C
6H
4)PPh
2}(Cl)]PF
6.CH
3CN
[49] and triclinic [Pt{η
3-Ph
2P(CH
2)
2S(=O)(CH
2)
2PPh
2}(Cl)]ClO
4 [50], the Cl
− anion completed a square planar geometry (PtP
1S
1P
2Cl).
Figure 3. Structure of [Pt{η3-Ph2P(C6H4)S(=O)(C6H4)PPh2}(CH3)].
In triclinic [Pt{η
3-Ph
2P(C
6H
4)S(=O)(C
6H
4)PPh
2}(P
3Ph
3)]0.5.CH
2Cl
[49] (at 100 K) and orthorhombic [Pt{η
3-Ph
2P(CH
2)
2S(CH
2)
2PPh
2}(P
3Ph
3)]ClO
4 [51] (at 100 K), the P
3Ph
3 are involved (PtP
1S
1P
2P
3).
In another triclinic [Pt{η
3-Ph
2P(C
23H
28S)PPh
2}(I)].1.74 CH
2Cl
2 [52] (at 150 K), the I
− anion is involved (PtP
1S
1P
2I).
The total mean PL-L bond distance elongates in the sequences:
Pt (η3-P1S1P2)(Y), Y = CL, Cl, P3L, I (6 examples): Pt–S1: (trans to Y): 2.187 (2,5) Å (Cl) < 2.256 (2) Å (I) < 2.268 (2) Å (C) < 2.328 (2,15) Å (P3); Pt–Y: (trans to S1): 2.093 (2) Å (C) < 2.285 (2,3) Å (P3) < 2.317 (2,5) Å (Cl) < 2.510 (1) Å (I); Pt–P1,2: (mutually trans) is 2.300 (4,30) Å.
2.5. Pt(η3–P1Si1P2)(Y), (Y = H (x2), OL (x1), NL (x1), CL (x1), Cl (x5), P3L (x1))
There are fourteen complexes in which each heterotridentate ligand creates a pair of “equal” five-membered metallocyclic rings with a common Si
1 atom of the P
1C
2Si
1C
2P
2 type. In two monoclinic [Pt{η
3-cy
2P(C
6H
4)Si(Me)(C
6H
4)Pcy
2}(H)].0.5 pentane
[53] (at 150 K) and [Pt{η
3-cy
2P(C
6H
4)Si(Me)(C
6H
4)Pcy
2}(H)].1.25 pentane
[53] (at 93 K), hydride completed a square planar geometry (PtP
1Si
1P
2H).
Triclinic [Pt{η
3-Ph
2P(C
6H
4)Si(Me)(C
6H
4)PPh
2}(OEt
2)]{B(C
6F
5)
3 (CH
2Ph)}.OEt
2 [54] (
Figure 4) is the only example with a monodentate OEt
2 ligand (PtP
1Si
1P
2O).
Figure 4. Structure of [Pt{η3-Ph2P(C6H4)Si(Me)(C6H4)PPh2}(OEt2)].
In another triclinic [Pt{η
3-Pr
i2P
1(C
6H
4)Si
1(C
6H
4PPr
i2)(C
6H
4)P
2Pr
i2}(NC
5H
5)]B(C
8H
3F
6)
4 [55] (at 100 K), a monodentate NC
5H
5 is involved (PtP
1Si
1P
2N).
In the following four complexes: triclinic [Pt{η
3-cy
2P(C
6H
4)Si(Me)(C
6H
4)Pcy
2}(Ph)]OEt
2 [54] (at 173 K), triclinic [Pt{η
3-Ph
2P(C
6H
4)Si(Me)(C
6H
4)PPh
2}(CH
2Ph)]CH
2Cl
2 [54] (at 193 K), triclinic [Pt{η
3-Pr
i2P)(C
6H
4)Si(OH)(C
6H
4)PPr
i2)}(CO)]B(C
6F
5)
4 [56] (at 120 K), and orthorhombic [Pt{η
3-Pr
i2P(C
6H
4)Si(H)(C
6H
4)PPr
i2}(mes)]
[57] (at 110 K), monodentate CL ligands are involved (PtP
1Si
1P
2C).
In the following five complexes: monoclinic [Pt{η
3-Ph
2P(C
6H
4)Si(Me)(C
6H
4)PPh
2}(Cl)]
[54] (at173 K), orthorhombic [Pt{η
3-Ph
2P(C
6H
4)Si(Me)(C
6H
4)PPh
2}(ClAlCl
3)](C
6H
5F)
2 [54] (at 193 K), monoclinic [Pt{η
3-Pr
i2P(C
6H
4)Si(OH)(C
6H
4)PPr
i2}(Cl)]
[56] (at 120 K), monoclinic [Pt{η
3-Pr
i2P(C
6H
4)Si(H)(C
6H
4)Pcy
2}(Cl)]
[57] (at 110 K), and monoclinic [Pt{η
3-cy
2P(C
6H
4)Si(Me)(C
6H
4)Pcy
2}(Cl)]
[58] (at 110 K), tridentate P
1Si
1P
2 with Cl
− anions construct inner coordination spheres around each Pt(II) atom (PtP
1Si
1P
2Cl).
The total mean PL-L bond distance elongates in the following sequences:
Pt (η3-P1Si1P2)(Y), Y = H, OL, NL, CL, Cl, P3L (19 examples): Pt–Si1: (trans to Y): 2.276 (2) Å (O) < 2.279 (2,6) Å (Cl) < 2.315 (2) Å (N) < 2.331 (2,5) Å (H) < 2.339 (2,17) Å (C) < 2.369 (2) Å (P3); Pt–Y: 1.51 (1,2) Å (H) < 2.122 (2,6) Å (C) < 2.222 (2) Å (N) < 2.282 (2) Å (O) < 2.316 (2) Å (P3) < 2.451 (2,13) Å (Cl); Pt–P1,2: (mutually trans) is 2.289 (2,32) Å.
The structure of monoclinic [Pt{η
3-Ph
2P
1(C
6H
4)Si
1(Me)(C
6H
4)P
2Ph
2}(P
3Ph
3)]
[59] (at 123 K) is shown in
Figure 5. In a distorted trigonal–pyramidal geometry, three P atoms construct a trigonal plane, and the Si
1 atom occupies a pyramid. The heterotridentate P
1Si
1P
2 ligand forms a pair of “equal” five-membered metallocyclic rings with a common Si
1 atom of the P
1C
2Si
1C
2P
2 type, with the mean P
1–Pt–Si
1/Si
1–Pt–P
2 bite angles of 83.3 (1,8)°. The values for the remaining angles are 120.7 (2)° (P
1–Pt–P
2), 119.6 (2,2.4)° (P
1–Pt–P
3/P
3–Pt–P
2), and 108.9 (2)° (Si
1–Pt–P
3). The Pt-L bond distance elongates in the following order: 2.290 (2.11) Å (Pt–P
1, Pt–P
2) < 2.318 (2) Å (Pt–P
3) < 2.369 (2) Å (Pt–Si
1). This is the only example of such geometries.
Figure 5. Structure of [Pt{η3-Ph2P(C6H4)Si(Me)(C6H4)PPh2}(PPh3)].